Marie Walton
Dunwoody, GANPI 1962061226
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,478,109in research payments, 2019–2025
Across 156 payments — averaging $9475.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vanda Pharmaceuticals Inc.$720K
- Eli Lilly$277K
- Sanofi US Services Inc.$211K
- Sanofi$97K
- GSK$39K
- AstraZeneca$36K
- plus $98K from 8 others
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.